Casdin Capital, LLC Generation Bio Co. Transaction History

Casdin Capital, LLC

  • $1.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$4.87 - $9.41 $6.45 Million - $12.5 Million
-1,324,275 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$20.0 - $27.43 $5.74 Million - $7.87 Million
-286,939 Reduced 17.81%
1,324,275 $33.2 Million
Q2 2020

Aug 14, 2020
BUY
$20.1 - $24.69 $32.4 Million - $39.8 Million
1,611,214 New
1,611,214 $33.8 Million

Others Institutions Holding GBIO

# of Institutions
76
Shares Held
49.6M
Call Options Held
0
Put Options Held
0
View Full List

About Generation Bio Co.

GBIO Quotes by TradingView
  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $60.2M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Casdin Capital, LLC Portfolio

Follow Casdin Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Casdin Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email